155213-67-5 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-02-24
Product Details
- Product NameRitonavir
- CAS No.155213-67-5
- EINECS No.605-001-5
- MFC37H48N6O5S2
- MW720.94
- Appearancepowderwhite to beige
- Melting point 120-122°C
- storage temp. room temp
- Boiling point 947.0±65.0 °C(Predicted)
- density 1.239±0.06 g/cm3(Predicted)
- Water Solubility 5mg/L(ms)
Company Profile Introduction
BDR Group of companies has grown steadily and become a house-hold name in the pharmaceutical Industry over the last 15 years, in both domestic and international arenas. We are recognized as a “niche” player in manufacturing of Pharmaceutical APIs and for our renowned new age formulations. The group is complemented majorly by its two companies - BDR Pharmaceuticals International Pvt Ltd and BDR Life sciences Pvt. Ltd, each one having stamped its own supremacy in respective fields, i.e. API and formulation manufacturing, respectively.
BDR Group focuses on development in 4 specialized therapeutic segments, viz. Oncology, Critical care, Gynecology & Neurology, which are its dream segments.
Over the years, BDR has built an undeniable reputation for its specialization in early identification, development and introduction of new molecules, in a continuous endeavor to make globally available high cost medicines to local masses at affordable prices;
Innovation and development are the inalienable cornerstones of BDR group. We invest heavily in R&D activities, possess state–of-the-art API and Formulation development centers accredited by the DSIR, Government of India. Our facilities are in a state of constant & continuous upgradation, so as to keep up and meet with the constantly growing demands of the dynamic International scenario. Blending of human skill and innovative expertise of BDR often acts as a catalyst for development of desired modern technology and setting up of world class facilities.
Supplier other products
Recommended supplier
-
VIP1年
- Molsyns Research
- 155213-67-5 Ritonavir Reference Standard 98%
- Inquiry
- 2024-04-01
-
VIP1年
- Raks Pharma Pvt Ltd
- 155213-67-5 99%
- Inquiry
- 2024-03-27
-
VIP1年
- Mylan Laboratories Ltd
- 155213-67-5 Ritonavir 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Vishrudh laboratories pvt ltd
- Ritonavir 155213-67-5 98%
- Inquiry
- 2024-03-01
-
VIP1年
- ShreeGen Pharma Ltd (part of Rumit Group of Companies)
- Ritonavir 98%
- Inquiry
- 2024-02-29
-
VIP1年
- Lavybens Pharma
- 155213-67-5 Ritonavir 98%
- Inquiry
- 2024-02-15
-
VIP1年
- Arene Lifesciences Limited
- Ritonavir 155213-67-5 99%
- Inquiry
- 2024-02-05
-
VIP1年
- Atul Bioscience Ltd
- Ritonavir 99%
- Inquiry
- 2024-02-05
-
VIP1年
- Ralington Pharma
- 155213-67-5 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Raising Sun Pharma
- 155213-67-5 Ritonavir 98%
- Inquiry
- 2024-02-03
- Since:2021-02-01
- Address: "?Engineering Center? 6th Floor,_x000D_ 9th Matthew Road, Opera House, Mumbai, Maharashtra-400004,